Download PDF
Horm Metab Res 2005; 37(2): 126
DOI: 10.1055/s-2005-861314
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells

G.  G.  Holz1
  • 1Department of Physiology and Neuroscience, New York University School of Medicine, USA
Further Information

Publication History

Received 7 July 2004

Accepted after revision 18 August 2004

Publication Date:
21 March 2005 (online)

Also available at
    Permissions and Reprints

Correction to:

New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-CellsHorm Metab Res 2004; 36(11/12): 787-794
DOI: 10.1055/s-2004-826165

G. Holz. New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells. Horm Metab Res 2004; 36: 787 - 774

1. The author's name must read G. G. Holz, not only G. Holz.

2. On page 788, second column, the first sentence must read: “From the standpoint of its usefulness as a treatment for type 2 diabetes mellitus, the glucose-dependent insulin secretagogue action of GLP-1 is of therapeutic importance.“

      >